V. Caractéristiques, H. El-serag, S. Sweet, C. Winchester, and J. Dent, Update on the epidemiology of gastrooesophageal reflux disease: a systematic review, Gut. juin, vol.63, issue.6, pp.871-80, 2014.

S. Bruley-des-varannes, L. Marek, B. Humeau, M. Lecasble, and C. R. , Gastroesophageal reflux disease in primary care, Gastroent??rologie Clinique et Biologique, vol.30, issue.3, pp.364-70, 2006.
DOI : 10.1016/S0399-8320(06)73189-X

M. Hoshino, A. Sundaram, and S. Mittal, Role of the Lower Esophageal Sphincter on Acid Exposure Revisited with High-Resolution Manometry, Journal of the American College of Surgeons, vol.213, issue.6, pp.743-50, 2011.
DOI : 10.1016/j.jamcollsurg.2011.09.002

N. Trudgill and S. Riley, Transient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers, The American Journal of Gastroenterology, vol.44, issue.9, pp.2569-74, 2001.
DOI : 10.1046/j.1365-2982.1998.00126.x

G. Koek, J. Tack, D. Sifrim, T. Lerut, and J. Janssens, The role of acid and duodenal gastroesophageal reflux in symptomatic GERD, The American Journal of Gastroenterology, vol.116, issue.7, pp.2033-2073, 2001.
DOI : 10.1088/0967-3334/15/1/005

H. Beaumont, R. Bennink, J. De-jong, and G. Boeckxstaens, The position of the acid pocket as a major risk factor for acidic reflux in healthy subjects and patients with GORD, Gut, vol.59, issue.4, pp.441-51, 2010.
DOI : 10.1136/gut.2009.178061

M. Simrén, J. Silny, R. Holloway, J. Tack, J. Janssens et al., Relevance of ineffective oesophageal motility during oesophageal acid clearance, Gut, vol.52, issue.6, pp.784-90, 2003.
DOI : 10.1136/gut.52.6.784

B. Jovov, J. Que, N. Tobey, Z. Djukic, B. Hogan et al., Role of E-cadherin in the Pathogenesis of Gastroesophageal Reflux Disease, The American Journal of Gastroenterology, vol.102, issue.6, pp.1039-1086, 2011.
DOI : 10.1111/j.1572-0241.2007.01179.x

P. Matthews, Q. Aziz, P. Facer, J. Davis, D. Thompson et al., Increased capsaicin receptor TRPV1 nerve fibres in the inflamed human oesophagus, European Journal of Gastroenterology & Hepatology, vol.16, issue.9, pp.897-902, 2004.
DOI : 10.1097/00042737-200409000-00014

M. Phillips, L. Gregory, S. Cullen, S. Coen, V. Ng et al., The effect of negative emotional context on neural and behavioural responses to oesophageal stimulation, Brain, vol.126, issue.3, pp.669-84, 2003.
DOI : 10.1093/brain/awg065

C. Knowles and Q. Aziz, Visceral hypersensitivity in non-erosive reflux disease, Gut, vol.57, issue.5, pp.674-83, 2008.
DOI : 10.1136/gut.2007.127886

P. Moayyedi, N. Talley, M. Fennerty, and N. Vakil, Can the clinical history distinguish between organic and functional dyspepsia? JAMA. 5 avr, pp.1566-76, 2006.

J. Richter, Gastroesophageal Reflux Disease as a Cause of Chest Pain, Medical Clinics of North America, vol.75, issue.5, 2000.
DOI : 10.1016/S0025-7125(16)30399-6

D. Book, J. Rhee, R. Toohill, and T. Smith, Perspectives in Laryngopharyngeal Reflux: An International Survey, The Laryngoscope, vol.87, issue.8, pp.1399-406, 2002.
DOI : 10.1097/00005537-200208000-00014

L. Houghton, J. Smith, P. Ducrotté, T. Vallot, A. Garofano et al., Gastro-oesophageal reflux events: just another trigger in chronic cough? Gut. 25 avr 2017 Gastroesophageal reflux disease: impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study, Bruley des Varannes S, pp.200-206, 2013.

I. Wiklund, Review of the Quality of Life and Burden of Illness in Gastroesophageal Reflux Disease, Digestive Diseases, vol.22, issue.2, pp.108-122, 2004.
DOI : 10.1159/000080308

F. Johnsson, B. Joelsson, K. Gudmundsson, and L. Greiff, Symptoms and Endoscopic Findings in the Diagnosis of Gastroesophageal Reflux Disease, Scandinavian Journal of Gastroenterology, vol.5, issue.6, pp.714-722, 1987.
DOI : 10.1007/BF01320258

A. Bredenoord, B. A. Weusten, and A. Smout, Symptom association analysis in ambulatory gastro-oesophageal reflux monitoring, Gut, vol.54, issue.12, pp.1810-1817, 2005.
DOI : 10.1136/gut.2005.072629

G. Wiener, J. Richter, J. Copper, W. Wu, and D. Castell, The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring, Am J Gastroenterol. avr, vol.83, issue.4, pp.358-61, 1988.

B. Weusten, J. Roelofs, L. Akkermans, G. Van-berge-henegouwen, and A. Smout, The symptomassociation probability: an improved method for symptom analysis of 24-hour esophageal pH data Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico, 1741?5. 22. Remes-Troche JM, pp.2382-2388, 1994.

C. Prakash and R. Clouse, Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease, Clinical Gastroenterology and Hepatology, vol.3, issue.4, pp.329-363, 2005.
DOI : 10.1016/S1542-3565(05)00021-2

S. Charbel, F. Khandwala, and M. Vaezi, The Role of Esophageal pH Monitoring in Symptomatic Patients on PPI Therapy, The American Journal of Gastroenterology, vol.19, issue.1, pp.283-292, 2005.
DOI : 10.1016/S0892-1997(02)00132-7

F. Zerbib, S. Roman, A. Ropert, S. Varannes, P. Pouderoux et al., Esophageal pHimpedance monitoring and symptom analysis in GERD: a study in patients off and on therapy

R. Harvey, P. Gordon, N. Hadley, D. Long, T. Gill et al., EFFECTS OF SLEEPING WITH THE BED-HEAD RAISED AND OF RANITIDINE IN PATIENTS WITH SEVERE PEPTIC OESOPHAGITIS, The Lancet, vol.330, issue.8569, pp.1200-1203, 1987.
DOI : 10.1016/S0140-6736(87)91332-8

M. Singh, J. Lee, N. Gupta, S. Gaddam, B. Smith et al., Weight loss can lead to resolution of gastroesophageal reflux disease symptoms: A prospective intervention trial, Obesity, vol.101, issue.2, pp.284-90, 2013.
DOI : 10.1111/j.1572-0241.2006.00723.x

M. Kwiatek, S. Roman, A. Fareeduddin, J. Pandolfino, and P. Kahrilas, An alginate-antacid formulation (Gaviscon Double Action Liquid) can eliminate or displace the postprandial ???acid pocket??? in symptomatic GERD patients, Alimentary Pharmacology & Therapeutics, vol.15, issue.1, pp.59-66, 2011.
DOI : 10.1185/03007999909114086

K. Bardhan, S. Müller-lissner, M. Bigard, B. Porro, G. Ponce et al., Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine, BMJ, vol.318, issue.7182, pp.502-509, 1999.
DOI : 10.1136/bmj.318.7182.502

P. Kahrilas, N. Shaheen, and M. Vaezi, American Gastroenterological Association Institute Technical Review on the Management of Gastroesophageal Reflux Disease, Gastroenterology, vol.135, issue.4, pp.1392-413, 2008.
DOI : 10.1053/j.gastro.2008.08.044

Y. Kinoshita, M. Hongo, T. Japan, and . Group, Efficacy of Twice-Daily Rabeprazole for Reflux Esophagitis Patients Refractory to Standard Once-Daily Administration of PPI: The Japan-Based TWICE Study, The American Journal of Gastroenterology, vol.21, issue.4, pp.522-552, 2012.
DOI : 10.1001/jama.292.23.2890

P. Katz and D. Castell, Current medical treatment and indications for surgical referral for gastroesophageal reflux disease (GERD), Semin Thorac Cardiovasc Surg. avr, vol.9, issue.2, pp.169-72, 1997.

J. A. Broeders, . Jl, F. Mauritz, A. Ali, U. Draaisma et al., Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease Perioperative risk of laparoscopic fundoplication: safer than previously reported-analysis of the American College of Surgeons National Surgical Quality Improvement Program, Br J Surg. sept J Am Coll Surg. juill, vol.97215, issue.91, pp.61-68, 2005.

J. Galmiche, J. Hatlebakk, S. Attwood, C. Ell, R. Fiocca et al., Laparoscopic Antireflux Surgery vs Esomeprazole Treatment for Chronic GERD, JAMA, vol.305, issue.19, pp.1969-77, 2011.
DOI : 10.1001/jama.2011.626

S. Spechler, E. Lee, D. Ahnen, R. Goyal, I. Hirano et al., Long-term Outcome of Medical and Surgical Therapies for Gastroesophageal Reflux Disease, JAMA, vol.285, issue.18, pp.2331-2339, 2001.
DOI : 10.1001/jama.285.18.2331

L. Khaitan, W. Ray, M. Holzman, and W. Smalley, Health Care Utilization After Medical and Surgical Therapy for Gastroesophageal Reflux Disease, Archives of Surgery, vol.138, issue.12, pp.1356-61, 1960.
DOI : 10.1001/archsurg.138.12.1356

P. Weijenborg, F. Cremonini, A. Smout, and A. Bredenoord, PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis, Neurogastroenterology & Motility, vol.23, issue.Suppl 2, pp.747-350, 2012.
DOI : 10.1111/j.1365-2036.2006.02945.x

H. El-serag, A. Becher, and R. Jones, Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies, Alimentary Pharmacology & Therapeutics, vol.32, issue.Suppl C, pp.720-757, 2010.
DOI : 10.1136/bmj.319.7209.550

R. Fass, Proton Pump Inhibitor Failure???What Are the Therapeutic Options?, The American Journal of Gastroenterology, vol.26, issue.2, pp.33-38, 2009.
DOI : 10.1016/0016-5085(87)90979-6

R. Fass, U. Murthy, C. Hayden, I. Malagon, G. Pulliam et al., Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre study, Alimentary Pharmacology and Therapeutics, vol.112, issue.12, pp.1595-603, 2000.
DOI : 10.1046/j.1365-2036.1998.00379.x

Y. Kinoshita, M. Hongo, T. Japan, and . Group, Efficacy of Twice-Daily Rabeprazole for Reflux Esophagitis Patients Refractory to Standard Once-Daily Administration of PPI: The Japan-Based TWICE Study, The American Journal of Gastroenterology, vol.21, issue.4, pp.522-552, 2012.
DOI : 10.1001/jama.292.23.2890

W. Fackler, T. Ours, M. Vaezi, and J. Richter, Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough, Gastroenterology, vol.122, issue.3, pp.625-657, 2002.
DOI : 10.1053/gast.2002.31876

N. Manabe, K. Haruma, M. Ito, N. Takahashi, H. Takasugi et al., Efficacy of adding sodium alginate to omeprazole in patients with nonerosive reflux disease: a randomized clinical trial, Diseases of the Esophagus, vol.25, issue.5, pp.373-80, 2012.
DOI : 10.1111/j.1442-2050.2011.01276.x

D. Sifrim and F. Zerbib, Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors, Gut, vol.61, issue.9, pp.1340-54, 2012.
DOI : 10.1136/gutjnl-2011-301897

I. Mainie, R. Tutuian, and D. Castell, The Limitations of pH Monitoring for Detecting Gastroesophageal Reflux, Clinical Gastroenterology and Hepatology, vol.4, issue.9, pp.1184-1185, 2006.
DOI : 10.1016/j.cgh.2006.06.002

G. Hemmink, A. Bredenoord, B. Weusten, J. Monkelbaan, R. Timmer et al., Esophageal pH-Impedance Monitoring in Patients With Therapy-Resistant Reflux Symptoms: ???On??? or ???Off??? Proton Pump Inhibitor?, The American Journal of Gastroenterology, vol.3, issue.10, pp.2446-53, 2008.
DOI : 10.1111/j.1572-0241.2006.00945.x

J. Wu, L. Lai, D. Chow, G. Wong, J. Sung et al., Concomitant irritable bowel syndrome is associated with failure of step-down on-demand proton pump inhibitor treatment in patients with gastro-esophageal reflux disease, Neurogastroenterology & Motility, vol.18, issue.2, pp.155-60, 2011.
DOI : 10.1007/s00464-003-8162-5

B. Nojkov, J. Rubenstein, S. Adlis, M. Shaw, R. Saad et al., The influence of co-morbid IBS and psychological distress on outcomes and quality of life following PPI therapy in patients with gastro-oesophageal reflux disease, Alimentary Pharmacology & Therapeutics, vol.32, issue.Suppl. 2, pp.473-82, 2008.
DOI : 10.1111/j.1572-0241.2006.00844.x

A. Ciccaglione and L. Marzio, Effect of acute and chronic administration of the GABAB agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease, Gut, vol.52, issue.4, pp.464-70, 2003.
DOI : 10.1136/gut.52.4.464

C. Keywood, M. Wakefield, and J. Tack, A proof-of-concept study evaluating the effect of ADX10059, a metabotropic glutamate receptor-5 negative allosteric modulator, on acid exposure and symptoms in gastro-oesophageal reflux disease, Gut, vol.58, issue.9, pp.1192-1201, 2009.
DOI : 10.1136/gut.2008.162040

N. Viazis, A. Keyoglou, A. Kanellopoulos, G. Karamanolis, J. Vlachogiannakos et al., Selective Serotonin Reuptake Inhibitors for the Treatment of Hypersensitive Esophagus: A Randomized, Double-Blind, Placebo-Controlled Study, The American Journal of Gastroenterology, vol.17, issue.11, pp.1662-1669, 2012.
DOI : 10.1046/j.1365-2036.2003.01469.x

G. Campos, J. Peters, T. Demeester, S. Oberg, P. Crookes et al., Multivariate analysis of the factors predicting outcome after laparoscopic Nissen fundoplication, Gastroenterology, vol.114, issue.3, pp.292-300, 1999.
DOI : 10.1016/S0016-5085(98)85609-6

Y. Khajanchee, D. Hong, P. Hansen, and L. Swanström, Outcomes of antireflux surgery in patients with normal preoperative 24-hour pH test results, The American Journal of Surgery, vol.187, issue.5, pp.599-603, 2004.
DOI : 10.1016/j.amjsurg.2004.01.010

J. Broeders, W. Draaisma, A. Bredenoord, D. De-vries, R. Jong et al., Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication, British Journal of Surgery, vol.220, issue.9, pp.1023-1053, 2009.
DOI : 10.1016/S0016-5085(08)63365-X

J. Broeders, W. Draaisma, A. Bredenoord, A. Smout, I. Broeders et al., Impact of symptom-reflux association analysis on long-term outcome after Nissen fundoplication, British Journal of Surgery, vol.244, issue.Suppl 1, pp.247-54, 2011.
DOI : 10.1016/0016-5085(94)90815-X

F. Zerbib, S. Roman, A. Ropert, S. Varannes, P. Pouderoux et al., Esophageal pHimpedance monitoring and symptom analysis in GERD: a study in patients off and on therapy

S. Emerenziani, D. Sifrim, F. Habib, M. Ribolsi, M. Guarino et al., Presence of gas in the refluxate enhances reflux perception in non-erosive patients with physiological acid exposure of the oesophagus, Gut, vol.57, issue.4, pp.443-450, 2008.
DOI : 10.1136/gut.2007.130104

E. Savarino, R. Tutuian, P. Zentilin, P. Dulbecco, D. Pohl et al., Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance???pH Off Therapy, The American Journal of Gastroenterology, vol.40, issue.5, pp.1053-61, 2010.
DOI : 10.1046/j.1365-2036.2003.01702.x

E. Savarino, P. Zentilin, R. Tutuian, D. Pohl, D. Casa et al., The Role of Nonacid Reflux in NERD: Lessons Learned From Impedance-pH Monitoring in 150 Patients off Therapy, The American Journal of Gastroenterology, vol.93, issue.Suppl 7, pp.2685-93, 2008.
DOI : 10.1056/NEJM198212163072503

N. Yoshida, M. Kuroda, T. Suzuki, K. Kamada, K. Uchiyama et al., Role of nociceptors/neuropeptides in the pathogenesis of visceral hypersensitivity of nonerosive reflux disease Multimodal induction and assessment of allodynia and hyperalgesia in the human oesophagus, 2237?43. 62. Drewes AM, pp.539-588, 2003.

S. Sarkar, Q. Aziz, C. Woolf, A. Hobson, D. Thompson et al., Contribution of central sensitisation to the development of non-cardiac chest pain Prevalence of eosinophilic esophagitis in patients with refractory gastroesophageal reflux disease symptoms: A prospective study. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment, 1154?9. 64. García-Compeán D204?8. 65. Poh CH, pp.28-34, 2000.

V. Kushnir, G. Sayuk, and C. Gyawali, The Effect of Antisecretory Therapy and Study Duration on Ambulatory Esophageal pH Monitoring, Digestive Diseases and Sciences, vol.55, issue.5, pp.1412-1421, 2011.
DOI : 10.1136/gut.2005.074690

E. Savarino, P. Zentilin, M. Martinato, and V. Savarino, Nonerosive reflux disease and functional heartburn are clearly separate entities, European Journal of Gastroenterology & Hepatology, vol.25, issue.6, pp.749-50, 2013.
DOI : 10.1097/MEG.0b013e32835df280

A. Bredenoord, W. Draaisma, B. A. Weusten, H. Gooszen, and A. Smout, Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery, Gut, vol.57, issue.2, pp.161-167, 2008.
DOI : 10.1136/gut.2007.133298

I. Mainie, R. Tutuian, A. Agrawal, D. Adams, and D. Castell, Combined multichannel intraluminal impedance???pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication, British Journal of Surgery, vol.199, issue.12, pp.1483-1490, 2006.
DOI : 10.1016/S0039-6060(98)70071-6

E. Savarino, E. Marabotto, P. Zentilin, M. Frazzoni, G. Sammito et al., The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver, juill, vol.43, issue.7, pp.542-549, 2011.

F. Zerbib, K. Belhocine, M. Simon, M. Capdepont, F. Mion et al., Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease, Gut, vol.61, issue.4, pp.501-507, 2012.
DOI : 10.1136/gutjnl-2011-300798

M. Frazzoni, R. Conigliaro, V. Mirante, and G. Melotti, The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn, Neurogastroenterology & Motility, vol.54, issue.2, pp.141-147, 2012.
DOI : 10.1136/gut.2005.072629

I. Mainie, R. Tutuian, S. Shay, M. Vela, X. Zhang et al., Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring, Gut, vol.55, issue.10, pp.1398-402, 2006.
DOI : 10.1136/gut.2005.087668

S. Blaga, T. Dumitrascu, D. Galmiche, J. , B. Varannes et al., Functional heartburn: clinical characteristics and outcome, 282?90. 75. Fass R, Tougas G. Functional heartburn: the stimulus, the pain, and the brain, pp.885-92, 2002.

M. Vela, B. Craft, N. Sharma, J. Freeman, and D. Hazen-martin, Refractory Heartburn: Comparison of Intercellular Space Diameter in Documented GERD vs. Functional Heartburn, The American Journal of Gastroenterology, vol.56, issue.5, pp.844-50, 2011.
DOI : 10.1136/gut.2006.113688

R. Farré, K. Blondeau, D. Clement, M. Vicario, L. Cardozo et al., Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique, Gut, vol.60, issue.7, pp.885-92, 2011.
DOI : 10.1136/gut.2010.233049

M. Kern, C. Hofmann, J. Hyde, and R. Shaker, Characterization of the cerebral cortical representation of heartburn in GERD patients, AJP: Gastrointestinal and Liver Physiology, vol.286, issue.1, pp.174-181, 2004.
DOI : 10.1152/ajpgi.00184.2003

M. Yang, Z. Li, D. Chen, D. Zou, X. Xu et al., Quantitative Assessment and Characterization of Visceral Hyperalgesia Evoked by Esophageal Balloon Distention and Acid Perfusion in Patients With Functional Heartburn, Nonerosive Reflux Disease, and Erosive Esophagitis, The Clinical Journal of Pain, vol.26, issue.4, pp.326-357, 2010.
DOI : 10.1097/AJP.0b013e3181c8fc83

B. Naliboff, M. Mayer, R. Fass, L. Fitzgerald, L. Chang et al., The Effect of Life Stress on Symptoms of Heartburn, Psychosomatic Medicine, vol.66, issue.3, pp.426-460, 2004.
DOI : 10.1097/01.psy.0000124756.37520.84

B. Johnston, S. Lewis, J. Collins, R. Mcfarland, and A. Love, Acid perception in gastrooesophageal reflux disease is dependent on psychosocial factors, Scand J Gastroenterol. janv, vol.30, issue.1, pp.1-5, 1995.

E. Park, M. Choi, M. Baeg, C. Lim, J. Kim et al., The Value of Early Wireless Esophageal pH Monitoring in Diagnosing Functional Heartburn in Refractory Gastroesophageal Reflux Disease, Digestive Diseases and Sciences, vol.43, issue.10, pp.2933-2942, 2013.
DOI : 10.1016/j.dld.2011.01.016

J. Ponce, V. Ortiz, N. Maroto, M. Ponce, M. Bustamante et al., High Prevalence of Heartburn and Low Acid Sensitivity in Patients with Idiopathic Achalasia, Digestive Diseases and Sciences, vol.46, issue.suppl 2, pp.773-779, 2011.
DOI : 10.1023/A:1010639232137

J. Limsrivilai, P. Charatcharoenwitthaya, N. Pausawasdi, S. Leelakusolvong, B. Saeidi et al., Imipramine for Treatment of Esophageal Hypersensitivity and Functional Heartburn: A Randomized Placebo- Controlled Trial Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: Double-blind placebocontrolled trial, Am J Gastroenterol. févr Neurogastroenterol Motil, vol.11126, issue.25, pp.670-678, 2014.

M. Shapiro, R. Shanani, H. Taback, D. Abramowich, E. Scapa et al., Functional chest pain responds to biofeedback treatment but functional heartburn does not, European Journal of Gastroenterology & Hepatology, vol.24, issue.6, pp.708-722, 2012.
DOI : 10.1097/MEG.0b013e3283525a0c

I. Bjelland, A. Dahl, T. Haug, and D. Neckelmann, The validity of the Hospital Anxiety and Depression Scale, Journal of Psychosomatic Research, vol.52, issue.2, pp.69-77, 2002.
DOI : 10.1016/S0022-3999(01)00296-3

J. Labus, R. Bolus, L. Chang, I. Wiklund, J. Naesdal et al., The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale, Alimentary Pharmacology and Therapeutics, vol.60, issue.8, pp.89-97, 2004.
DOI : 10.1037//0022-006X.70.3.725

A. Mykletun, E. Stordal, A. Dahl, J. Slaughter, M. Goutte et al., Hospital Anxiety and Depression (HAD) scale: factor structure, item analyses and internal consistency in a large population Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease, 540?4. 91, pp.868-74, 2001.

S. Roman, L. Keefer, H. Imam, P. Korrapati, B. Mogni et al., Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux, Neurogastroenterology & Motility, vol.13, issue.11, pp.1667-74, 2015.
DOI : 10.1016/j.cgh.2014.11.035

E. Savarino, P. Zentilin, E. Marabotto, D. Bonfanti, S. Inferrera et al., Overweight is a risk factor for both erosive and non-erosive reflux disease, Digestive and Liver Disease, vol.43, issue.12, pp.940-945, 2011.
DOI : 10.1016/j.dld.2011.07.014

N. Talley, N. Vakil, P. Moayyedi, J. Pandolfino, O. Palsson et al., American gastroenterological association technical review on the evaluation of dyspepsia The feasibility and acceptability of esophagealdirected hypnotherapy for functional heartburn Predictive value of routine esophageal high-resolution manometry for gastro-esophageal reflux disease, 1756?80. 95. Riehl ME,490?6. 96. van Hoeij FB, pp.963-70, 2005.

Y. Shi, N. Tan, N. Zhang, L. Xiong, S. Peng et al., Predictors of proton pump inhibitor failure in non-erosive reflux disease: A study with impedance-pH monitoring and high-resolution manometry, Neurogastroenterology & Motility, vol.101, issue.5, pp.674-683, 2016.
DOI : 10.1111/j.1572-0241.2006.00711.x

D. Boltin, M. Boaz, S. Aizic, A. Sperber, R. Fass et al., Psychological distress is not associated with treatment failure in patients with gastroesophageal reflux disease The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease, 462?6. 99. Fass R, pp.696-705, 2008.

R. Dickman, M. Boaz, S. Aizic, R. Belfer, A. Sperber et al., Comparison of Anxiety and Depression in Gastroesophageal Reflux Disease (GERD) Patients Who Failed Proton Pump Inhibitor (PPI) Therapy Versus Those Who Fully Responded to it, Gastroenterology. 1 mai, vol.140, issue.5, p.582, 2011.

I. Nastaskin, E. Mehdikhani, J. Conklin, S. Park, and M. Pimentel, Studying the Overlap Between IBS and GERD: A Systematic Review of the Literature, Digestive Diseases and Sciences, vol.19, issue.Suppl 2, pp.2113-2133, 2006.
DOI : 10.1016/0016-5085(90)91079-L

E. Savarino, D. Pohl, P. Zentilin, P. Dulbecco, G. Sammito et al., Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease, Gut, vol.58, issue.9, pp.1185-91, 2009.
DOI : 10.1136/gut.2008.175810

N. De-bortoli, L. Frazzoni, E. Savarino, M. Frazzoni, I. Martinucci et al., Functional Heartburn Overlaps With Irritable Bowel Syndrome More Often than GERD, The American Journal of Gastroenterology, vol.15, issue.12, pp.1711-1718, 2016.
DOI : 10.1016/j.cgh.2011.07.009